BARDA is clearly playing by their own rules right now. Im sure this will either skyrocket or plunge way before any news is posted. Its great science, and with the roswell patient trials almost complete data should be extremely strong IMHO. I want to see dosage perfected for the radiation to the point of no doubt. If cleveland leaves any "doubt" on the table...well then we know what happens. In the contract award from BARDA being in the 50m range, we would double instantly with a gradual 2 year rise to 9 - 12 range before FDA decision in late 2015. Im in with just shy of 30k shares currently... no exactly chump change but willing to hold long term clearly as the profile name states.
Those of whom have been following CBLI for the past couple years have gone through many of these patterns before, none of which have been as important as the next hurdle for Cleveland. I just finished reading through the quarterlies and found it interesting that they attached an "other" section describing how additional funding could or could not shape Q2 of 2014 significantly. Burn rate of all projects was not terrible at 5m. Jean hopefully has something cooking as things begin to look extremely interesting for Cleveland going into this winter. Hope for the best, prepare for the worst.